XML 96 R73.htm IDEA: XBRL DOCUMENT v3.22.1
Redeemable Convertible Preferred Stock - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 6 Months Ended 12 Months Ended
Oct. 31, 2021
Apr. 30, 2020
Jun. 30, 2020
Dec. 31, 2021
Dec. 31, 2020
Jan. 01, 2021
Dec. 31, 2019
Temporary Equity [Line Items]              
Temporary equity, shares issued             7,375,631
Net proceeds from issuance of convertible preferred stock       $ 0 $ 72,468    
Outstanding shares of redeemable convertible preferred stock       0 0 0 7,375,631
Common Stock              
Temporary Equity [Line Items]              
Purchase shares of common stock       4,875,715 9,660,000    
Series C Redeemable Convertible Preferred Stock              
Temporary Equity [Line Items]              
Temporary equity, shares issued     4,200,353        
Temporary equity, shares issued price per share     $ 18.00        
Net proceeds from issuance of convertible preferred stock     $ 72,500        
Funding Agreement Product | CFF              
Temporary Equity [Line Items]              
Additional funding upon acceptance of investigational New Drug application   $ 4,000          
Additional investment in cash $ 4,000            
Funding Agreement Product | CFF | Common Stock              
Temporary Equity [Line Items]              
Purchase shares of common stock 125,715            
Funding Agreement Product | CFF | Series C Redeemable Convertible Preferred Stock              
Temporary Equity [Line Items]              
Investment in redeemable convertible preferred stock financing   $ 10,000